Genmab Announces Phase III Studies of Ofatumumab in Relapsing Multiple Sclerosis
June 02, 2016 01:43 ET
|
Genmab A/S
Company Announcement
Phase III trials (ASCLEPIOS I and II) with the subcutaneous formulation of ofatumumab in Relapsing Multiple Sclerosis
Studies expected to begin enrolling in September...
SDRL - Anton Dibowitz appointed Executive Vice President
June 02, 2016 01:30 ET
|
Seadrill Limited
Hamilton, Bermuda, June 2, 2016 - The Board of Seadrill Limited ("Seadrill") has appointed Anton Dibowitz as Executive Vice President of Seadrill Management Ltd. He will continue to report to CEO,...
Solvay takes full ownership of joint venture stake in U.S. cellulose acetate flake plant from Eastman Chemical Company
June 02, 2016 01:30 ET
|
Solvay S.A.
Brussels, June 2, 2016 --- Solvay has completed the purchase of Eastman Chemical Company's share in their former U.S. joint venture Primester. As the sole owner of the cellulose acetate flake...
Boussard & Gavaudan Holding Ltd (GBP): NAV(s)
June 02, 2016 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
Boussard & Gavaudan Holding Ltd (EUR): NAV(s)
June 02, 2016 01:30 ET
|
BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
BOUSSARD...
Correction of previously published press releaseCorrection of previously published press release
June 02, 2016 01:30 ET
|
Resurs Holding AB
The press release published by Resurs Holding AB (publ) at 8.30 am CET on 1 June
2016, “Exercise of Over-allotment in Relation to Resurs and Notice of
Stabilization” included incorrect information...
Korrigering av tidigare distribuerat pressmeddelande
June 02, 2016 01:30 ET
|
Resurs Holding AB
I det pressmeddelande Resurs Holding AB (publ) distribuerade kl. 08.30 CET den 1
juni 2016, ” Utnyttjande av övertilldelningsoption i Resurs och
stabiliseringsåtgärder”, förekom felaktig information...
Novartis drug Afinitor® receives EU approval to treat certain types of advanced gastrointestinal (GI) and lung neuroendocrine tumors (NET)
June 02, 2016 01:15 ET
|
Novartis Pharma AG
Afinitor fills critical need in EU as first approved therapy for advanced, progressive, nonfunctional lung NET and first oral therapy for this type of GI NET Nonfunctional GI and lung NET are rare...
Addex Annual General Meeting Scheduled for 23 June 2016
June 02, 2016 01:15 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}
Geneva, Switzerland 2 June 2016 -...
Samu Konttinen appointed as new CEO of F-Secure, Christian Fredrikson resigns
June 02, 2016 01:00 ET
|
F-Secure Oyj
F-Secure Corporation, Stock exchange release, 2 June 2016 at 08:00 EEST
Christian Fredrikson, President and CEO of...
- May 13, 2024 16:15 ET Duos Technologies Group Reports First Quarter 2024 Results
- May 13, 2024 16:05 ET Navitas Semiconductor to Participate in Upcoming Investor Events